Sign In
Buy GTHX
$7.15
+0 (+0%)
At Close: Dec 16, 2024
G1 Therapeutics (NASDAQ:GTHX) Shares Up 1.5%
06:15am, Wednesday, 24'th Jun 2020
G1 Therapeutics Inc (NASDAQ:GTHX)’s share price rose 1.5% during trading on Monday . The company traded as high as $23.77 and last traded at $24.09, approximately 16,651 shares traded hands during t
Needham & Company LLC Reiterates Buy Rating for G1 Therapeutics (NASDAQ:GTHX)
01:54am, Wednesday, 24'th Jun 2020
G1 Therapeutics (NASDAQ:GTHX)‘s stock had its “buy” rating reaffirmed by equities researchers at Needham & Company LLC in a research note issued to investors on Monday, AnalystRatings.com report
G1 Therapeutics and Genor Biopharma Announce Exclusive License Agreement for Lerociclib in Asia-Pacific Region
10:00am, Monday, 22'nd Jun 2020
G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, and Genor Biopharma Co. Inc., a pre-commercial stage biopharmaceutical company focused on developing and commercializing immune
Two Sigma Investments LP Has $1.33 Million Stock Holdings in G1 Therapeutics Inc (NASDAQ:GTHX)
08:02am, Monday, 22'nd Jun 2020
Two Sigma Investments LP grew its position in G1 Therapeutics Inc (NASDAQ:GTHX) by 81.0% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 121
G1 Therapeutics (NASDAQ:GTHX) Rating Lowered to Hold at Zacks Investment Research
02:18am, Sunday, 21'st Jun 2020
G1 Therapeutics (NASDAQ:GTHX) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Friday, Zacks.com reports. According to Zacks, “G1 Th
Zacks Investment Research Upgrades G1 Therapeutics (NASDAQ:GTHX) to Buy
01:48am, Friday, 19'th Jun 2020
G1 Therapeutics (NASDAQ:GTHX) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to investors on Wednesday, Zacks.com reports. The broke
Needham: 3 Conviction Buy Stocks to Snap up Now
04:27pm, Thursday, 18'th Jun 2020
For investors feeling perplexed by the stock market’s roller coaster ride in 2020, you’re not alone. Following up a week that saw volatility make a comeback, stocks popped for the third session in
2 Top Cancer Treatment Stocks to Buy in June
11:09am, Tuesday, 16'th Jun 2020
Investors with extra cash on the sidelines may be able to capture some exciting cancer stocks at attractive prices. One company received approval from the Food and Drug Administration (FDA) for its c
How G1 Therapeutics (GTHX) Stock Stands Out in a Strong Industry
12:36pm, Thursday, 11'th Jun 2020
G1 Therapeutics (GTHX) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Acadian Asset Management LLC Makes New $65,000 Investment in G1 Therapeutics Inc (NASDAQ:GTHX)
05:06am, Wednesday, 10'th Jun 2020
Acadian Asset Management LLC purchased a new position in shares of G1 Therapeutics Inc (NASDAQ:GTHX) in the first quarter, according to the company in its most recent 13F filing with the Securities an
Rhumbline Advisers Purchases 2,192 Shares of G1 Therapeutics Inc (NASDAQ:GTHX)
04:12am, Wednesday, 10'th Jun 2020
Rhumbline Advisers increased its position in G1 Therapeutics Inc (NASDAQ:GTHX) by 4.8% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Com
Jun 09, 2020 (The Expresswire) --
"Final Report will add the analysis of the impact of COVID-19 on this industry." Our research report “Estrogen and...
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 1)
Adaptimmune Therapeutics PLC...
G1 Therapeutics Announces Flexible Credit Financing for Up to $100 Million with Hercules Capital
08:01pm, Monday, 01'st Jun 2020
G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced that the company has entered into a debt financing agreement with Hercules Capital, Inc. (NYSE: HTGC) for up to
- Trilaciclib significantly reduced myelosuppression and need for related supportive care interventions for patients with small cell lung cancer (SCLC) receiving chemotherapy -.
